Of note, CD8+ T cells contributed to the anti-tumor effects of targeting circAtxn7, as evidenced by equal susceptibility to MC38K tumor inoculation in circAtxn7CKO and WT mice after CD8+ T cell depletion (Supplementary Fig. 11E, F). This evidence concerns the gene CD8A and neoplasm.